Redox-Triggered Nanomedicine via Lymphatic Delivery: Inhibition of Melanoma Growth by Ferroptosis Enhancement and a Pt(IV)-Prodrug Chemoimmunotherapy Approach (2022)

First Author: Bilbao-Asensio M
Attributed to:  Swansea University – Confidence in Concept 2019 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/adtp.202200179

Publication URI: http://dx.doi.org/10.1002/adtp.202200179

Type: Journal Article/Review

Parent Publication: Advanced Therapeutics

Issue: 2